# Comparing Hydrus Microstent(TM) to the iStent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery

> **NCT02024464** · NA · COMPLETED · sponsor: **Ivantis, Inc.** · enrollment: 306 (actual)

## Conditions studied

- Primary Open Angle Glaucoma
- Pseudoexfoliative Glaucoma
- Pigmentary Dispersion Glaucoma

## Interventions

- **DEVICE:** Hydrus Microstent
- **DEVICE:** iStent Trabecular Micro Bypass
- **PROCEDURE:** Cataract removal and intraocular lens (IOL) implantation

## Key facts

- **NCT ID:** NCT02024464
- **Lead sponsor:** Ivantis, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2017-03
- **Final completion:** 2018-08
- **Target enrollment:** 306 (ACTUAL)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02024464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02024464, "Comparing Hydrus Microstent(TM) to the iStent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02024464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*